Research OnlyGrowth hormone secretagogue

CJC-1295

Also known as:CJC-1295 DACCJC-1295 no DACmodified GRF 1-29

Unapproved Research CompoundReference literature only. Compound is not cleared by regulatory authorities for human therapeutic administration or self-medication.

Class: Growth hormone secretagogue
GLP-1 relevance: No

How it works

GHRH analog / GH secretagogue

Approved & studied uses

Unapproved anti-aging / body composition claims

Regulatory status

Unapproved; FDA safety-risk concerns for compounding

Safety notes

FDA identified serious adverse events and limited data for CJC-1295.

Sources

FDA Category 2 peptides

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.